Title : Innovative therapy of ovarian cancer based on overexpression of CD44 receptor.

Pub. Date : 2015 May

PMID : 26117979






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Overexpression of CD44, observed in many ovarian cancer cells, is used in creating carriers for selective delivery of various drugs (paclitaxel, doxorubicin, camptothecin or cisplatin) to cancer cells. Paclitaxel CD44 molecule (Indian blood group) Homo sapiens